Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The evolution and improvisation of this class can be seen through the development of Fc-enhanced tumor-activated anti-CTLA-4 inhibitors (Xilio's Therapeutics' Vilastobart) which also deplete ...

Craniopharyngiomas are brain tumors that negatively impact the hormonal function of the nearby pituitary. The tumor location often prevents necessary surgical intervention. Alternative pharmacological ...

Craniopharyngioma (CP) is a rare brain tumor that develops in the regions close to the hypothalamus and pituitary gland. The ...

Company continuing to advance DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ...

Craniopharyngiomas are brain tumors that negatively impact the hormonal function of the nearby pituitary. The tumor location ...

Craniopharyngioma (CP) is a rare brain tumor that develops in the regions close to the hypothalamus and pituitary gland. The CP tumors lead to ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

The Radiation Research Centre of Excellence (RadNet-CoE) at The Institute of Cancer Research and The Royal Marsden brings together preeminent leaders in radiotherapy, immunotherapy, cancer biology, ...

引言近年来，癌症免疫治疗的兴起为多种恶性肿瘤的治疗带来了新的希望，其中免疫检查点抑制剂（Immune Checkpoint Blockade, ICB）显著改变了非小细胞肺癌（Non-Small-Cell Lung Cancer, ...